GET73 modulates rat hippocampal glutamate transmission: evidence for a functional interaction with mGluR(5).
Journal Title: Pharmacological Reports - Year 2011, Vol 63, Issue 6
Abstract
In the present study, the effects of the γ-hydroxybutyrate (GHB) analog GET73 on hippocampal glutamate transmission have been evaluated by an approach combining in vivo microdialysis with the in vitro evaluation of tissue slices. The microdialysis results indicated that local perfusion (60 min) with 10 nM - 1mM GET73 increased extracellular glutamate levels in the CA1 region of the hippocampus of freely moving rats in a concentration dependent manner. In tissue slices from the rat hippocampus, GET73 (1 μM - 10 μM) did not affect L-[(3)H]glutamate uptake, whereas treatment with 1 μM GET73 significantly increased K(+)-evoked, but not spontaneous, glutamate efflux. The GHB analog did not affect the increase in glutamate efflux induced by 100 μM and 300 μM NMDA. In contrast, 500 nM GET73, a concentration at which it is ineffective alone, partially but significantly counteracted the increase in K(+)-evoked glutamate efflux induced by 100 μM CHPG, an mGluR5 agonist. When 500 nM GET73 was coperfused with 100 μM MPEP, it amplified the decrease in K(+)-evoked glutamate efflux induced by the mGluR5 antagonist. Interestingly, the increase in K(+)-evoked glutamate efflux induced by 1 μM GET73 was counteracted by coperfusion with a low (10 μM) concentration of MPEP, which by itself is ineffective. Finally, 500 nM GET73 did not affect the reduction of K(+)-evoked glutamate efflux induced by the mGluR2/3 agonist LY379268. These findings demonstrate that the GHB analog GET73 significantly affects glutamate transmission in the hippocampus, and its profile of action differs from that of its parent compound.
Authors and Affiliations
Luca Ferraro, Sarah Beggiato, Maria Cristina Tomasini, Tiziana Antonelli, Antonella Loche, Sergio Tanganelli
Keywords
Related Articles
- EP ID EP119561
- DOI -
- Views 93
- Downloads 0
Effects of catecholamines on blood pressure in the long bone marrow cavity in rats with bisphosphonate-induced osteopetrosis.
Osteopetrosis is a congenital metabolic bone disease characterized by skeletal sclerosis resulting from defective osteoclast-mediated bone resorption. The disease may, inter alia, be caused by the administration of bisph...
Vascular prostaglandin synthesis: the early days.
Prostacyclin (PGI(2)) and thromboxane (TxA(2)) labile cyclooxygenase (COX) products via PGH(2) were identified in biological fluids by the ingenious application of the principle of parallel pharmacological assays develop...
Nicotine dependence - human and animal studies, current pharmacotherapies and future perspectives.
Nicotine dependence is a disease of constantly growing importance. This mini-review describes the effects of nicotine in humans and focuses on the various laboratory animal models developed to study the dependence-relate...
Nephroprotective effect of cystathionine is due to its diverse action on the kidney and Ehrlich ascites tumor cells.
Tumor cells, unlike normal cells, are characterized by trace cystathionase (CST) activity and sulfane sulfur levels. The present studies aimed to established whether cystathionine (CT), a substrate of cystathionase, can...
Dopaminergic drug-induced modulation of the expression of the dopamine transporter in peripheral blood lymphocytes in Parkinson's disease.
The modulation of expression of the dopamine transporter by dopaminergic drugs was investigated by flow cytometry in peripheral blood lymphocytes from patients suffering Parkinson's disease. An 8-week in vivo exposure to...